TY - JOUR T1 - Scale-free dynamics of Covid-19 in a Brazilian city JF - medRxiv DO - 10.1101/2021.09.10.21263332 SP - 2021.09.10.21263332 AU - J. M. P. Policarpo AU - A. A. G. F. Ramos AU - C. Dye AU - N. R. Faria AU - F. E. Leal AU - O. J. S. Moraes AU - K. V. Parag AU - P. S. Peixoto AU - E. C. Sabino AU - V. H. Nascimento AU - A. Deppman Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/15/2021.09.10.21263332.abstract N2 - Mathematical models can provide insights into the control of pandemic COVID-19, which remains a global priority. The dynamics of directly-transmitted infectious diseases, such as COVID-19, are usually described by compartmental models where individuals are classified as susceptible, infected and removed. These SIR models typically assume homogenous transmission of infection, even in large populations, a simplification that is convenient but inconsistent with observations. Here we use original data on the dynamics of COVID-19 spread in a Brazilian city to investigate the structure of the transmission network. We find that transmission can be described by a network in which each infectious individual has a small number of susceptible contacts, of the order of 2-5, which is independent of total population size. Compared with standard models of homogenous mixing, this scale-free, fractal infection process gives a better description of COVID-19 dynamics through time. In addition, the contact process explains the geographically localized clusters of disease seen in this Brazilian city. Our scale-free model can help refine criteria for physical and social distancing in order to more effectively mitigate the spread of COVID-19. We propose that scale-free COVID-19 dynamics could be a widespread phenomenon, a topic for further investigation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementA D is partially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil), grant 304244/2018-0, by Project INCT-FNA Proc. No. 464 898/2014-5 and by FAPESP grant 2016/17612-7. PSP is supported by FAPESP grant 16/18445-7. V H N is supported by CNPq, grant 304714/2018-6. This work was supported by a Medical Research Council-Sao Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389- 0) (https://caddecentre.org). Wellcome Trust and Royal Society (N.R.F.: Sir Henry Dale Fellowship: 204311/Z/16/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee (Comissao de Etica para Analise de Projeto de Pesquisa, protocol no. 13915, dated 3 June 2020). The committee waived the need for informed consent and allowed the development of an analytical dataset with no personal identification for the current analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the work is available in the manuscript and supplementary material. ER -